Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter PD-1 Antikörper

Dieser Kaninchen Monoklonal Antikörper detektiert spezifisch PD-1 in IHC und IF. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN7828483
328,90 €
Zzgl. Versandkosten 20,00 € und MwSt
50 μL
Lieferung nach: Deutschland
Lieferung in 9 bis 13 Werktagen

Kurzübersicht für Rekombinanter PD-1 Antikörper (ABIN7828483)

Target

Alle PD-1 (PDCD1) Antikörper anzeigen
PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 229
  • 141
  • 28
  • 9
  • 5
  • 3
  • 1
Human

Wirt

  • 125
  • 108
  • 66
  • 32
  • 13
  • 5
  • 4
  • 2
  • 2
  • 1
Kaninchen

Klonalität

  • 278
  • 70
  • 7
  • 2
Monoklonal

Konjugat

  • 184
  • 21
  • 19
  • 18
  • 14
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PD-1 Antikörper ist unkonjugiert

Applikation

  • 188
  • 103
  • 93
  • 74
  • 41
  • 31
  • 20
  • 18
  • 18
  • 16
  • 16
  • 13
  • 13
  • 13
  • 10
  • 10
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF)

Klon

A115
  • Verwendungszweck

    Recombinant PD1 Monoclonal Antibody

    Aufreinigung

    Protein A purified

    Immunogen

    Synthetic peptide derived from the human PD1 protein

    Isotyp

    IgG, kappa
  • Applikationshinweise

    IHC 1:200-1:1000,IF 1:50

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

    Haltbarkeit

    12 months
  • Target

    PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

    Andere Bezeichnung

    PD1

    Hintergrund

    SLEB,hSLE,Programmed Death,programmed cell death,Programmed cell death protein,Systemic lupus erythematosus susceptibility,hPD,PDCD1,CD279,PD-1,PD1,SLEB2,hPD-1,hPD-l,hSLE1,programmed cell death 1,PD 1,CD279 antigen,hPD 1,hPD l,PDCD 1,Programmed cell death 1 protein,Programmed Death-1,Protein PD 1,Protein PD-1,Systemic lupus erythematosus susceptibility 2,Programmed cell death protein 1,CD279,CD279 antigen,hPD 1,hPD l,hPD-1,hSLE1,PD 1,PD-1,PD1,PDCD 1,PDCD1,PDCD1,Programmed cell death 1,Programmed cell death 1 protein,Programmed cell death protein 1,Protein PD 1,Protein PD-1,SLEB2,Systemic lupus erythematosus susceptibility 2,The programmed cell death 1 protein (PD1) is an inhibitory receptor expressed on antigen activated T-cells that plays a critical role in the induction and maintenance of immune tolerance to self-antigens. Upon binding to its ligands CD274/PDCD1L1 (PD-L1) and CD273/PDCD1LG2 (PD-L2), PD1 is phosphorylated within its immunoreceptor tyrosine-based switch motif (ITSM), which facilitates the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2. PTPN11/SHP-2 then dephosphorylates key T-cell receptor (TCR) proximal signaling molecules, including ZAP70, PRKCQ/PKC theta and CD247/CD3 zeta, leading to the direct inhibition of T-cell activation. The PD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and evade destruction by the immune system, thereby facilitating tumor survival. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

    UniProt

    Q15116

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!